Read about the Wisconsin Investment Fund – a public-private venture capital initiative.

Biosciences/Medical Devices
QNBV
Axio BioPharma Inc.
504 S. Rosa Road, STE 200
Madison, Wisconsin 53719
Axio BioPharma is revolutionizing biopharmaceutical manufacturing by leveraging AI to accelerate the development of recombinant protein therapeutics, with an initial focus on monoclonal antibodies (mAbs). Our innovative approach significantly shortens the timeline from lab research to clinical readiness, increasing efficiency and reducing costs. Axio is committed to setting new standards in the biopharma industry and advancing therapeutic innovations
Go to Top